Jan 25, 2026
How do Ashkenazi-specific founder mutations affect genetic screening guidelines and clinical care?
—variants that rose to high frequency through historical bottlenecks—have shaped screening guidelines by concentrating testing on a limited set of high-yield variants for and targeted cancer-risk test...